DashboardPortafogliWatchlistCommunityScopriScreener
NOT FOR DISTRIBUTION

Concentrix Corporation

Report azionario NasdaqGS:CNXC

Capitalizzazione di mercato: US$1.7b

  • Panoramica aziendale
    • Valutazione
    • Crescita futura
    • Performance passate
    • Salute finanziaria
    • Dividendo
  • Management
  • Proprietà
  • Altre informazioni
  • Comunità azionaria

Concentrix Salute del bilancio

Criteri Salute finanziaria verificati 1/6

Concentrix ha un patrimonio netto totale di $2.7B e un debito totale di $4.6B, che porta il suo rapporto debito/patrimonio netto a 169.7%. Le sue attività totali e le sue passività totali sono rispettivamente $10.5B e $7.8B. L'EBIT di Concentrix è $620.7M rendendo il suo rapporto di copertura degli interessi 2.2. Ha liquidità e investimenti a breve termine pari a $255.6M.

Informazioni chiave

169.73%

Rapporto debito/patrimonio netto

US$4.58b

Debito

Indice di copertura degli interessi2.2x
ContantiUS$255.57m
Patrimonio nettoUS$2.70b
Totale passivitàUS$7.81b
Totale attivitàUS$10.51b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Seeking Alpha • Sep 18

Concentrix: This AI Bargain Stock Could Be The Ultimate Value Trap - Strong Sell

Summary Concentrix appears deeply undervalued on adjusted free cash flow metrics relative to its sub-$2 billion market cap, but I think its valuations are a trap. Despite attractive valuation, CNXC’s AI initiatives may be cannibalizing its traditional revenue streams, complicating the investment case. Recent financials suggest CNXC’s AI-driven cost reductions could undermine its own growth prospects. I remain bearish, as the company’s strategic shift raises concerns about long-term revenue sustainability. Read the full article on Seeking Alpha
User avatar
Aggiornamento narrativa • Sep 17

CNXC: Guidance Reset And Risk Expansion Will Shape Earnings Path Forward

Concentrix now carries an updated analyst fair value estimate of $30.00, up from $26.00, with analysts pointing to revised long term assumptions on revenue growth and profit margins following recent price target resets in the $26 to $45 range. Analyst Commentary Recent Street research on Concentrix shows a clear tilt toward more cautious expectations, with several bearish analysts trimming price targets after the latest fiscal Q2 report.
User avatar
Aggiornamento narrativa • Jul 21

CNXC: Guidance Reset And Investigation Will Shape Earnings Trajectory

For Concentrix, the analyst fair value estimate has been reduced from $54.00 to $26.00. Analysts cited softer revenue assumptions, higher discount rates, and updated earnings forecasts following fiscal Q2 results and revised guidance.
User avatar
Aggiornamento narrativa • Jul 07

CNXC: Reset Expectations And Index Shift Will Support Future Upside Potential

Analysts have lowered the Concentrix fair value estimate from $41.25 to $35.25, reflecting reduced long term revenue growth assumptions. Profit margin expectations and the future P/E input also shift in response to updated models following recent Q2 results and guidance.
User avatar
Aggiornamento narrativa • Jun 23

CNXC: Margin Resilience And Index Shift Will Support Repriced Upside Potential

Analysts have trimmed their price targets on Concentrix by $12 to $25, citing updated assessments of the company’s outlook while keeping key assumptions such as fair value at $41.25 and long term revenue growth and profit margin broadly unchanged. Analyst Commentary Recent research on Concentrix points to a more cautious stance on valuation, with several firms trimming price targets while keeping long term growth and margin assumptions broadly intact.
User avatar
Aggiornamento narrativa • Jun 07

CNXC: Margin Expansion And Buybacks Will Support Repriced Upside Potential

Analysts have reduced their price targets on Concentrix by $12 to $25, citing updated views on the company’s outlook. They maintained their fair value estimates and kept key model inputs such as discount rate, revenue growth, profit margin, and future P/E broadly unchanged.
User avatar
Aggiornamento narrativa • May 13

CNXC: Margin Resilience And Buybacks Will Support Repriced Upside Potential

Concentrix's analyst price target has been revised lower by a combined $24 to $25 across several firms, with analysts citing updated views on valuation and business outlook to support the adjustment. Analyst Commentary Across the latest research updates, analysts reduced their price targets for Concentrix by amounts ranging from $12 to $25, pointing to reassessments of valuation and the business outlook.
User avatar
Aggiornamento narrativa • Apr 25

CNXC: Margin Resilience And Buybacks Will Support Future Upside Potential

Analysts have trimmed their Concentrix price targets by $12 to $25, citing more conservative assumptions around future P/E multiples, while keeping fair value, discount rate, and margin expectations broadly unchanged. Analyst Commentary Bullish Takeaways Bullish analysts appear to see the P/E reset as a way to align expectations more closely with current sentiment, which can reduce the risk of overpaying for near term execution.
User avatar
Aggiornamento narrativa • Apr 10

CNXC: Higher Margin Outlook And Buybacks Will Support Future Upside Potential

Narrative Update The updated analyst price target for Concentrix moves from approximately $48.60 to about $41.25. This reflects recent cuts from several firms as analysts point to more measured revenue growth assumptions, offset by slightly higher projected profit margins and a lower future P/E multiple.
User avatar
Aggiornamento narrativa • Mar 27

CNXC: Higher Margin Outlook And Buybacks Will Support Future Undervalued Entry

The analyst price target for Concentrix has shifted from $62.20 to $48.60. Analysts attribute this change to updated assumptions around slower revenue growth, a higher profit margin profile, and a lower future P/E multiple following recent target cuts from Barrington, Baird, and Canaccord.
User avatar
Aggiornamento narrativa • Mar 12

CNXC: AI Rollout And Buybacks Will Support Future Undervalued Entry

Analysts have trimmed their price target on Concentrix by $4, reflecting updated views captured in recent research while keeping key fair value and growth assumptions essentially unchanged. Analyst Commentary Recent research around the $4 reduction in the price target highlights a mix of confidence in Concentrix’s core thesis and a more cautious stance on execution and risk.
User avatar
Aggiornamento narrativa • Feb 26

CNXC: Higher Discount Rate Assumptions Will Support Future Undervalued Entry

Analysts have trimmed their price target on Concentrix by $4, reflecting updated assumptions around discount rates and valuation multiples, while keeping fair value estimates for the business broadly unchanged. Analyst Commentary Analysts describe the $4 price target cut as a fine tuning of their models rather than a reset of their overall view on Concentrix, with fair value estimates broadly intact.
Articolo di analisi • Feb 16

Benign Growth For Concentrix Corporation (NASDAQ:CNXC) Underpins Stock's 30% Plummet

Concentrix Corporation ( NASDAQ:CNXC ) shareholders won't be pleased to see that the share price has had a very rough...
User avatar
Aggiornamento narrativa • Feb 12

CNXC: Updated Discount Rate Assumptions Will Support Future Undervalued Entry

Analysts have lowered their price target on Concentrix by $4, citing updated assumptions around discount rates and profitability, while keeping fair value estimates broadly stable. Analyst Commentary Analysts describe the recent US$4 reduction in the price target as a fine tuning of their view, reflecting updated discount rate assumptions and a more cautious stance on profitability, rather than a fundamental reset of Concentrix's underlying worth.
User avatar
Aggiornamento narrativa • Jan 29

CNXC: Updated Discount Rate And P/E Assumptions Will Support Future Undervalued Entry

Narrative Update on Concentrix Analysts have trimmed their price target on Concentrix by $4, citing updated assumptions around discount rates and future P/E expectations, while keeping their fair value estimate unchanged at $62.20. Analyst Commentary Recent research around Concentrix reflects a mixed tone, with the $4 trim to the price target tied mainly to updated discount rate inputs and revised P/E assumptions rather than a reset of the underlying fair value, which remains at $62.20.
User avatar
Aggiornamento narrativa • Jan 15

CNXC: Higher Discount Rate Reset Will Support Future Undervalued Entry Thesis

Analysts have trimmed their price target on Concentrix by about $2.63, citing updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E following recent research that included a $4 reduction highlighted at Baird. Analyst Commentary Analysts framing the new price target are trying to line up their fair value work with updated assumptions on discount rates, revenue growth, margins and the future P/E they think the market is willing to pay for Concentrix.
Articolo di analisi • Nov 08

Concentrix Corporation (NASDAQ:CNXC) Not Doing Enough For Some Investors As Its Shares Slump 28%

The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...
Articolo di analisi • Sep 29

Concentrix's (NASDAQ:CNXC) Upcoming Dividend Will Be Larger Than Last Year's

The board of Concentrix Corporation ( NASDAQ:CNXC ) has announced that it will be paying its dividend of $0.36 on the...
User avatar
Aggiornamento narrativa • Sep 27

AI Integration And Webhelp Synergies Will Transform Business

Concentrix's consensus price target was modestly reduced to $64.83 as analysts factor in compressed valuation multiples from AI-related investor uncertainty and secular headwinds—rather than fundamental weakness—while maintaining confidence in growth reacceleration and strong business fundamentals. Analyst Commentary Compressed valuation multiples attributed to investor uncertainty over the impact of artificial intelligence on labor-intensive business models and broader secular headwinds, not due to fundamental company weakness.
Articolo di analisi • Apr 03

Concentrix Corporation's (NASDAQ:CNXC) Shares Leap 26% Yet They're Still Not Telling The Full Story

The Concentrix Corporation ( NASDAQ:CNXC ) share price has done very well over the last month, posting an excellent...
Articolo di analisi • Jan 29

The Market Lifts Concentrix Corporation (NASDAQ:CNXC) Shares 25% But It Can Do More

Concentrix Corporation ( NASDAQ:CNXC ) shareholders have had their patience rewarded with a 25% share price jump in the...
Seeking Alpha • Jan 17

Concentrix: Better Than Expected Results, GenAI, And Cheap

Summary Concentrix Corporation delivered better-than-expected EPS and revenue, driven by significant investments in its GenAI product suite and a booming AI customer experience market. The AI in customer experience market is projected to grow at a 22% CAGR, potentially boosting CNXC's future revenue and free cash flow growth. Despite risks from high debt levels and potential global tariffs, CNXC's substantial headcount growth and consistent net income make it appear undervalued. My financial model suggests CNXC is significantly undervalued, with an equity valuation of $6.5 billion and a target price of $102 per share. Read the full article on Seeking Alpha
Seeking Alpha • Dec 21

AI: Will Freshworks Leave Room For Concentrix?

Summary A.I. is revolutionising Customer Relationship Management (CRM), with Salesforce leading the market, leveraging Big Data to enhance customer interactions and sales conversions. Generative A.I. significantly boosts Customer Experience (CX) performance, with early adopters seeing a 25% increase in CX satisfaction, and the global CX market projected to grow to $33bn by 2030. Concentrix, with a $2.86bn market cap, offers comprehensive CX services including call centres. Freshworks is a SAAS only CX provider. Both companies have seen 70% plus share price declines, but one is still priced for growth, the other for business declines. Is this justified? Read the full article on Seeking Alpha

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $3.0B ) di CNXC superano le sue passività a breve termine ( $2.6B ).

Passività a lungo termine: Le attività a breve termine di CNXC ( $3.0B ) non coprono le sue passività a lungo termine ( $5.2B ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 160.3% ) di CNXC è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di CNXC è aumentato da 37.9% a 169.7% negli ultimi 5 anni.

Copertura del debito: Il debito di CNXC non è ben coperto dal flusso di cassa operativo ( 16.2% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di CNXC non sono ben coperti dall'EBIT ( 2.2 x copertura).


Bilancio


Scoprire le aziende sane

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/09/20 00:51
Prezzo dell'azione a fine giornata2026/09/18 00:00
Utili2026/05/31
Utili annuali2025/11/30

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
  • Modulo SEC 10-K
  • Modulo SEC 10-Q
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
  • Rapporti di ricerca degli analisti
  • Blue Matrix
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
  • Dati di mercato ICE
  • Modulo SEC S-1
Proprietà10 anni
  • Top azionisti
  • Insider trading
  • Modulo 4 SEC
  • Modulo 13D SEC
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
  • Modulo SEC 10-K
  • Modulo SEC DEF 14A
Sviluppi principali10 anni
  • Annunci aziendali
  • Modulo 8-K SEC

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Concentrix Corporation è coperta da 5 analisti. 3 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
David KoningBaird
Vincent ColicchioBarrington Research Associates, Inc.
Ruplu BhattacharyaBofA Global Research

Prendi decisioni di investimento migliori ovunque

Scansiona per scaricare
Apri App StoreApri Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Visualizza le fonti dei dati
Mercati
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Idee di investimento
  • Società sottovalutate
  • Titoli a forte dividendo
  • Acquisto da parte di insider
  • Energia nucleare
  • Veicoli autonomi
  • Intelligenza artificiale
  • Cripto e blockchain
  • Cybersecurity
  • Altre idee
Comunità azionarie
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Funzionalità e strumenti
  • Tracker del portafoglio
  • Stock screener e avvisi
  • Narrazioni e valori equi
  • Calcolatore di dividendi
Notizie e scoperta
  • Ultime notizie sulle azioni
  • Approfondimenti sui mercati globali
  • La tana della volpe
  • Idee di investimento
  • Narrazioni della community
  • Novità
Simply Wall St
  • Piani e prezzi
  • Pubblicità
  • Chi siamo
  • Contattaci
  • Carriere
  • Centro assistenza
  • Impara a investire in azioni
  • Programma di affiliazione
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Termini e condizioni
  • Informativa sulla privacy
  • Termini sull'IA
  • Guida ai servizi finanziari